Case number 3:18-cv-14209
VALEANT PHARMACEUTICALS NORTH AMERICA LLC et al v. TEVA PHARMACEUTICALS USA, INC. et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Apr 15, 2019 | 20 | Order (7) Docket Text: ORDER CONSOLIDATING CASES FOR ALL PURPOSES. Civil Action No. 18-13635 shall be the Lead Case and effective upon entry of this order, all filings in the Consolidated Actions are to be made only in Civil Action No. 18-13635. Signed by Judge Peter G. Sheridan on 4/15/2019. (mmh) |
| Apr 15, 2019 | N/A | Terminated Case (0) Docket Text: ***Civil Case Administratively Terminated. (mmh) |
| Mar 21, 2019 | N/A | Pretrial Conference - Initial (0) Docket Text: Text Minute Entry for proceedings held before Magistrate Judge Lois H. Goodman: Initial Pretrial Conference held on 3/21/2019 via Conference Call. (if, ) |
| Mar 20, 2019 | 19 | Main Document (20) Docket Text: ANSWER to Complaint with JURY DEMAND by TEVA PHARMACEUTICAL INDUSTRIES LTD., TEVA PHARMACEUTICALS USA, INC.. (Attachments: # (1) 7.1 Statement)(WALSH, LIZA) |
| Mar 20, 2019 | 19 | 7.1 Statement (2) |
| Mar 20, 2019 | 19 | Answer to Complaint (20) |
| Mar 1, 2019 | 18 | Stipulation and Order (3) Docket Text: STIPULATION AND ORDER that the time for Defendants to respond to Plaintiffs' Complaint for Patent Infringement in this action is extended to 3/20/2019. Signed by Magistrate Judge Lois H. Goodman on 3/1/2019. (mmh) |
| Feb 22, 2019 | 17 | Letter (1) |
| Feb 22, 2019 | 17 | Main Document (1) Docket Text: Letter from Liza M. Walsh to the Honorable Lois H. Goodman, U.S.M.J. encl. Stipulation and proposed Order. (Attachments: # (1) Stipulation and proposed Order)(WALSH, LIZA) |
| Feb 22, 2019 | 17 | Stipulation and proposed Order (3) |
| Feb 22, 2019 | 16 | Order (5) Docket Text: ORDER SCHEDULING CONFERENCE: Scheduling Conference set for 3/21/2019 10:00 AM in Trenton - Courtroom 7E before Magistrate Judge Lois H. Goodman. Signed by Magistrate Judge Lois H. Goodman on 2/22/2019. (mps) |
| Feb 5, 2019 | 15 | Stipulation and Order (2) Docket Text: STIPULATION AND ORDER that the time for Defendants to answer, move, or otherwise respond to Plaintiffs' Complaint is extended to 2/26/2019. Signed by Magistrate Judge Lois H. Goodman on 2/5/2019. (mps) |
| Feb 1, 2019 | 14 | Letter (1) |
| Feb 1, 2019 | 14 | Main Document (1) Docket Text: Letter from Liza M. Walsh to the Honorable Lois H. Goodman, U.S.M.J. encl. Stipulation and proposed Order. (Attachments: # (1) Stipulation and proposed Order)(WALSH, LIZA) |
| Feb 1, 2019 | 14 | Stipulation and proposed Order (3) |
| Feb 1, 2019 | 13 | Notice of Appearance (2) Docket Text: NOTICE of Appearance by HECTOR DANIEL RUIZ on behalf of TEVA PHARMACEUTICAL INDUSTRIES LTD., TEVA PHARMACEUTICALS USA, INC. (RUIZ, HECTOR) |
| Feb 1, 2019 | 12 | Notice of Appearance (2) Docket Text: NOTICE of Appearance by LIZA M. WALSH on behalf of TEVA PHARMACEUTICAL INDUSTRIES LTD., TEVA PHARMACEUTICALS USA, INC. (WALSH, LIZA) |
| Dec 18, 2018 | 11 | Notice of Appearance (1) Docket Text: NOTICE of Appearance by JUSTIN JAMES HASFORD on behalf of KAKEN PHARMACEUTICAL CO., LTD. (HASFORD, JUSTIN) |
| Dec 11, 2018 | 9 | Waiver of Service Executed (1) Docket Text: WAIVER OF SERVICE Returned Executed by VALEANT PHARMACEUTICALS NORTH AMERICA LLC, KAKEN PHARMACEUTICAL CO., LTD., DOW PHARMACEUTICAL SCIENCES, INC., VALEANT PHARMACEUTICALS IRELAND LTD.. TEVA PHARMACEUTICALS USA, INC. waiver sent on 11/28/2018, answer due 1/28/2019. (LOWER, J.) |
| Dec 11, 2018 | 10 | Waiver of Service Executed (1) Docket Text: WAIVER OF SERVICE Returned Executed by VALEANT PHARMACEUTICALS NORTH AMERICA LLC, KAKEN PHARMACEUTICAL CO., LTD., DOW PHARMACEUTICAL SCIENCES, INC., VALEANT PHARMACEUTICALS IRELAND LTD.. TEVA PHARMACEUTICAL INDUSTRIES LTD. waiver sent on 11/28/2018, answer due 2/26/2019. (LOWER, J.) |
| Dec 5, 2018 | 8 | Notice of Appearance (1) Docket Text: NOTICE of Appearance by J. BRUGH LOWER on behalf of DOW PHARMACEUTICAL SCIENCES, INC., KAKEN PHARMACEUTICAL CO., LTD., VALEANT PHARMACEUTICALS IRELAND LTD., VALEANT PHARMACEUTICALS NORTH AMERICA LLC (LOWER, J.) |
| Oct 10, 2018 | N/A | QC - Incorrect Entry made by Clerk's Office Staff (0) Docket Text:CLERK'S QUALITY CONTROL MESSAGE - Please note the [5] AO120 Patent Form filed by the Clerk's office on 9/24/2018 was docketed in error. Please disregard. (jmh, ) |
| Sep 24, 2018 | 7 | Summons Issued (2) Docket Text: SUMMONS ISSUED as to TEVA PHARMACEUTICAL INDUSTRIES LTD., TEVA PHARMACEUTICALS USA, INC. Attached is the official court Summons, please fill out Defendant and Plaintiffs attorney information and serve. (jmh) |
| Sep 24, 2018 | 6 | AO120 Patent/Trademark Form (1) Docket Text: AO120 Patent Form filed. (jmh) |
| Sep 24, 2018 | N/A | AO120 Patent/Trademark Form (0) |
| Sep 24, 2018 | 4 | AO120 Patent/Trademark Form (1) Docket Text: AO120 Patent Form filed. (jmh) |
| Sep 24, 2018 | N/A | Add and Terminate Judges (0) Docket Text: Judge Peter G. Sheridan and Magistrate Judge Lois H. Goodman added. (jmh) |
| Sep 21, 2018 | 3 | Corporate Disclosure Statement (aty) (1) Docket Text: Corporate Disclosure Statement by KAKEN PHARMACEUTICAL CO., LTD.. (DENI, WILLIAM) |
| Sep 21, 2018 | 2 | Corporate Disclosure Statement (aty) (1) Docket Text: Corporate Disclosure Statement by DOW PHARMACEUTICAL SCIENCES, INC., VALEANT PHARMACEUTICALS IRELAND LTD., VALEANT PHARMACEUTICALS NORTH AMERICA LLC identifying Bausch Health Companies Inc. as Corporate Parent.. (DENI, WILLIAM) |
| Sep 21, 2018 | 1 | L. Civ. R. 11.2 Certification (2) |
| Sep 21, 2018 | 1 | Civil Cover Sheet (3) |
| Sep 21, 2018 | 1 | Exhibit H (11) |
| Sep 21, 2018 | 1 | Exhibit G (17) |
| Sep 21, 2018 | 1 | Exhibit F (14) |
| Sep 21, 2018 | 1 | Exhibit E (11) |
| Sep 21, 2018 | 1 | Exhibit D (17) |
| Sep 21, 2018 | 1 | Exhibit C (17) |
| Sep 21, 2018 | 1 | Main Document (25) Docket Text: COMPLAINT against TEVA PHARMACEUTICAL INDUSTRIES LTD., TEVA PHARMACEUTICALS USA, INC. ( Filing and Admin fee $ 400 receipt number 0312-9042846), filed by VALEANT PHARMACEUTICALS NORTH AMERICA LLC, KAKEN PHARMACEUTICAL CO., LTD., DOW PHARMACEUTICAL SCIENCES, INC., VALEANT PHARMACEUTICALS IRELAND LTD.. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Civil Cover Sheet, # (10) L. Civ. R. 11.2 Certification)(DENI, WILLIAM) |
| Sep 21, 2018 | 1 | Exhibit B (16) |
| Sep 21, 2018 | 1 | Exhibit A (15) |
| Sep 21, 2018 | 1 | Complaint (25) |
